Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
British Journal of Cancer
|
June 30, 2018
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra, Tanguy Y Seiwert, Shilpa Gupta, et al.
Investigational New Drugs
|
February 15, 2014
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach
Allyson J Ocean, Paul Christos, Joseph A Sparano, et al.
Diagnostics (Basel, Switzerland)
|
March 28, 2026
Can 3D T1 Post-Contrast MRI in A Radiomics-Machine Learning Model Distinguish Infective from Neoplastic Ring-Enhancing Brain Lesions? An Exploratory Study
Edwin Chong Yu Sng, Minh Bao Kha, Min Jia Wong, et al.
Future Oncology (London, England)
|
June 4, 2020
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412
Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, et al.
Cancer Medicine
|
December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancer
David G Pfister, Robert I Haddad, Francis P Worden, et al.
Nature Medicine
|
July 18, 2018
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim, Razvan Cristescu, Adam J Bass, et al.
Science (New York, N.Y.)
|
October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy
Razvan Cristescu, Robin Mogg, Mark Ayers, et al.
Nature
|
April 22, 2026
Glycerol-driven TNAP activation in thermogenesis and mineralization
Mohammed Faiz Hussain, Shreya S Krishnan, Brittany L Carroll, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
British Journal of Cancer
|
June 30, 2018
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra, Tanguy Y Seiwert, Shilpa Gupta, et al.
Investigational New Drugs
|
February 15, 2014
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach
Allyson J Ocean, Paul Christos, Joseph A Sparano, et al.
Diagnostics (Basel, Switzerland)
|
March 28, 2026
Can 3D T1 Post-Contrast MRI in A Radiomics-Machine Learning Model Distinguish Infective from Neoplastic Ring-Enhancing Brain Lesions? An Exploratory Study
Edwin Chong Yu Sng, Minh Bao Kha, Min Jia Wong, et al.
Future Oncology (London, England)
|
June 4, 2020
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412
Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, et al.
Cancer Medicine
|
December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancer
David G Pfister, Robert I Haddad, Francis P Worden, et al.
Nature Medicine
|
July 18, 2018
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim, Razvan Cristescu, Adam J Bass, et al.
Science (New York, N.Y.)
|
October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy
Razvan Cristescu, Robin Mogg, Mark Ayers, et al.
Nature
|
April 22, 2026
Glycerol-driven TNAP activation in thermogenesis and mineralization
Mohammed Faiz Hussain, Shreya S Krishnan, Brittany L Carroll, et al.
Page
of 8